Efficacy of intraperitoneal thermochemotherapy and immunotherapy in intraperitoneal recurrence after gastrointestinal cancer resection

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

307

HTML

2393

Tables (1-3)

226

Sum=2926

Dec 15, 2002 (publication date) through Feb 3, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Dec 15, 2002; 8(6): 1019-1022
Published online Dec 15, 2002. doi: 10.3748/wjg.v8.i6.1019

Table 3 The therapeutic efficiency of intraperitoneal thermochemotherapy combined with IL-2 immunotherapy

Groups	n	Intraperitoneal recurrent rate (%)	Hepatic metastasis rate(%)	3-year survival rate(%)
Group I	65	29.2(19/65)	16.9(11/65)	47.7(31/65)
Group II	73	12.3(9/73)^b	10.9(8/73)^a	65.8(48/73)^a

^aP < 0.05 vs control group,

^bP < 0.01 vs control group

Citation: Fu QG, Meng FD, Shen XD, Guo RX. Efficacy of intraperitoneal thermochemotherapy and immunotherapy in intraperitoneal recurrence after gastrointestinal cancer resection. World J Gastroenterol 2002; 8(6): 1019-1022
URL: https://www.wjgnet.com/1007-9327/full/v8/i6/1019.htm
DOI: https://dx.doi.org/10.3748/wjg.v8.i6.1019